Woman wins $4 million in Prempro breast cancer trial 
By:
Sylvia Hsieh
Published: April 27, 2012
Tags: breast cancer, drug litigation, hormone replacement therapy, HRT litigation, Pfizer, Prempro, Wyeth
A 65-year-old elementary school principal has won a $4 million verdict in Connecticut federal court against the maker of the menopause drug Prempro for causing her breast cancer.
Prempro plaintiff can’t show causation, District Court rules
Published: March 13, 2012
Tags: breast cancer, causation, failure to warn, hormone replacement therapy, Premarin, Prempro, product liability, Provera, Upjohn, Wyeth
A product liability plaintiff could not show that the alleged failure of pharmaceutical companies to warn about the dangers of their hormone therapy drugs was the proximate cause of her breast cancer, a U.S. District Court in South Carolina has ruled in granting summary judgment.
Pfizer settles nearly half of Prempro claims, adds to reserve
Published: December 29, 2011
Tags: hormone replacement therapy, Prempro, product liability, SEC, Securities and Exchange Commission
Drug maker Pfizer and its affiliates have settled nearly half of the product liability claims involving the hormone-replacement therapy drugs Prempro, Premarin and Provera, according to a regulatory filing.
Plaintiff’s expert can’t testify in Prempro case
Published: July 25, 2011
Tags: breast cancer, expert witness, hormone replacement therapy, Premarin, Prempro, product liability, Provera
A treating physician could not testify as an expert in a product liability lawsuit alleging that the plaintiff’s breast cancer was caused by her ingestion of hormone replacement therapy drugs, a U.S. District Court in West Virginia has ruled.
Small firm turns the tide on Prempro litigation
By:
Sylvia Hsieh
Published: January 18, 2011
Tags: breast cancer, hormone replacement therapy, hormone replacement therapy litigation, HRT litigation, Prempro, Wyeth, Wyeth Pharmaceuticals
In the ongoing mass tort over the hormone replacement therapy drug Prempro, two small firms recently teamed up to break the defense winning streak in the trials.
Drug litigation in review 2010
By:
Tony Ogden
Published: January 4, 2011
Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth
Much like 2009, 2010 was a busy year for prescription drug suits.
Hormone drug plaintiffs must show reliance
By:
Pat Murphy
Published: January 3, 2011
Tags: consumer protection, deceptive trade practices, hormone replacement therapy, product liability, reliance, Wyeth
Consumers must show detrimental reliance in order to hold a drug manufacturer liable for misleading statements in its marketing of hormone replacement therapy drugs, West Virginia’s highest court has ruled.
Pfizer wins latest trial in ongoing Prempro litigation
By:
Sylvia Hsieh
Published: October 27, 2010
Tags: hormone replacement therapy, HRT, Prempro, Wyeth Pfizer
A federal jury in Arkansas returned a defense verdict in a case against Pfizer over whether the hormone replacement therapy drug Prempro caused breast cancer in 81 year-old plaintiff Margaret Wilson.
Study: HRT drug boosts risk of cancer death
By:
Kimberly Atkins
Published: October 21, 2010
Tags: breast cancer, drug litigation, failure to warn, hormone replacement therapy, Pfizer, Prempro, Wyeth
Post-menopausal women who take a popular hormone drug combination therapy are at increased risk of getting breast cancer as well as dying from the disease, according to a new federal study.
Prempro trial under way in Arkansas
By:
Nora Tooher
Published: October 5, 2010
Tags: drug litigation, hormone replacement therapy, Premarin, Prempro, Wyeth
Proceedings have begun in the latest hormone replacement trial in federal multi-district litigation in U.S. District Court for the Eastern District of Arkansas.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
